Maryland Caps Diabetes Drug at $6.80 Per Pill

For millions of Americans struggling with diabetes and sky-high medication costs, Maryland just proved that states can fight back and win.

The Maryland Prescription Drug Affordability Board set its first-ever price cap on a medicine this week, targeting Jardiance, a widely prescribed type 2 diabetes treatment. Starting in January 2027, the state will limit what government programs pay for a 30-day supply to just $204, or $6.80 per pill.

The board operates like a state utility commission, stepping in when drug prices become unaffordable for residents. This marks only the second time any state panel in America has taken such action.

Maryland officials benchmarked the new price against what Medicare considers fair, then adjusted for inflation. The math matters: this single cap will save taxpayers an estimated $320,000 every year, money that can now go toward treating more patients or funding other healthcare needs.

Andrew York, the board's executive director, emphasized that the pricing reflects real-world affordability while still allowing the medication to reach patients who need it. The cap applies specifically to purchases by state and local government programs, protecting public health budgets from unsustainable drug costs.

The Ripple Effect

Maryland's move could inspire other states watching closely from the sidelines. With prescription drug costs continuing to climb nationwide, this successful price cap demonstrates that state governments have tools to protect their residents without waiting for federal action.

The impact extends beyond spreadsheets and budgets. Every dollar saved on overpriced medications is a dollar that can fund preventive care, expand access to treatment, or simply stay in the pockets of families already stretched thin by healthcare costs.

For people living with type 2 diabetes, affordable access to effective medication can mean the difference between managing their condition successfully and facing serious complications. Maryland's price cap removes one barrier between patients and the treatment they need.

More states are likely watching Maryland's experiment with interest, weighing whether similar boards could work in their communities. The success of this first cap could open doors for broader action on drug pricing across the country, turning one state's solution into a nationwide movement for affordability.